Direkt zum Inhalt
Merck
  • Highly asymmetric bromocyclization of tryptophol: unexpected accelerating effect of DABCO-derived bromine complex.

Highly asymmetric bromocyclization of tryptophol: unexpected accelerating effect of DABCO-derived bromine complex.

Organic letters (2014-03-29)
Huan Liu, Guangde Jiang, Xixian Pan, Xiaolong Wan, Yisheng Lai, Dawei Ma, Weiqing Xie
ZUSAMMENFASSUNG

Highly asymmetric bromocyclization of tryptophol by using chiral anionic phase-transfer catalyst and DABCO-derived brominating reagent is described. Optimization of the reaction conditions revealed that the reaction rate was accelerated together with improvement of enantioselectivity by addition of catalytic DABCO-derived brominating reagent. From tryptophol, 3-bromofuroindoline could be directly obtained in excellent enantioselectivities by employing this novel methodology.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
1,4-Diazabicyclo[2.2.2]octan, ReagentPlus®, ≥99%
Sigma-Aldrich
Dabco® 33-LV
Sigma-Aldrich
3-(2-Hydroxyethyl)-indol, 97%